.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07A_BacterialVaccines.J07AM52_TetanusToxoidCombinationsWithTet.TetanusToxoidCombinationsWithTet

Information

name:TetanusToxoidCombinationsWithTetanusImmunoglobulin
ATC code:J07AM52
route:intramuscular
n-compartments1

A combination product containing tetanus toxoid, a vaccine used to induce active immunity against tetanus, together with tetanus immunoglobulin, which provides passive immediate immunity to tetanus. It is typically used for post-exposure prophylaxis in individuals with risk of tetanus infection, especially when immunization status is uncertain or incomplete. Both components are approved and widely used for prevention of tetanus.

Pharmacokinetics

Estimated pharmacokinetic parameters for healthy adults; no direct pharmacokinetic studies or publications were found for the combination product.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos